This inventor holds 2 USPTO granted patents, plus 1 CIPO patent. Top assignees: Avicena Group, Inc., The General Hospital Corporation, Other. Active years: 2004-2007.
Company Filing History:
1 out of 4 
1 out of 3,067 
1 out of 834,307 Years Active: 2004-2007
Title: Ghaleb Daouk: Innovator in Neurological Treatments
Introduction
Ghaleb Daouk is a notable inventor based in Belmont, MA (US). He has made significant contributions to the field of neurological treatments through his innovative use of creatine compounds. With a total of 2 patents, his work focuses on addressing various diseases of the nervous system.
Latest Patents
Ghaleb Daouk's latest patents revolve around the use of creatine or creatine analogs for the treatment of diseases of the nervous system. His inventions detail the therapeutic effectiveness of creatine compounds, including creatine, creatine phosphate, and analogs such as cyclocreatine. These compounds are proposed as effective agents against a range of neurological disorders, including diabetic and toxic neuropathies, Alzheimer's disease, Parkinson's disease, and multiple sclerosis, among others. The patents describe various methods of utilizing these compounds, including their roles as substrates for creatine kinase and as inhibitors of this enzyme.
Career Highlights
Throughout his career, Ghaleb Daouk has worked with notable organizations, including Avicena Group, Inc. His experience in the field has allowed him to develop innovative solutions for complex neurological issues.
Collaborations
Ghaleb has collaborated with esteemed colleagues such as M Flint Beal and Rima Kaddurah-Daouk. These partnerships have contributed to the advancement of his research and the development of his patents.
Conclusion
Ghaleb Daouk's contributions to the field of neurological treatments through his innovative use of creatine compounds highlight his role as a significant inventor. His work continues to pave the way for new therapeutic approaches to complex diseases of the nervous system.